Ignite Creation Date:
2025-12-25 @ 4:01 AM
Ignite Modification Date:
2025-12-26 @ 2:54 AM
Study NCT ID:
NCT06918002
Status:
RECRUITING
Last Update Posted:
2025-07-16
First Post:
2024-12-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients
Sponsor:
Intergroupe Francophone du Myelome
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-09
Start Date Type:
ACTUAL
Primary Completion Date:
2036-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2036-05
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-10
First Submit QC Date:
None
Study First Post Date:
2025-04-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-11
Last Update Post Date:
2025-07-16
Last Update Post Date Type:
ACTUAL